Main Menu

How we work with industry

The Enterprise Unit has many industrial partners and works with them to transform ideas into new products for the benefit of cancer patients. We interact in a number of ways with commercial partners who can provide the resources and complementary expertise required to take our research findings through development, manufacture and into the clinic.

ScientistInLab8_874x492

Collaboration

The Institute of Cancer Research has a strong track record of working collaboratively with industry both in early stage research and to develop products. The Enterprise Unit supports industry and the ICR research community in working together on projects where each party brings their own experience and expertise to the work. We can also assist in finding external funding sources for work in partnership with the ICR.

Licensing

The Enterprise Unit works with ICR researchers to protect, market and licence technologies created in the ICR laboratories. The wide range of oncology research undertaken at the ICR constantly increases our portfolio of intellectual property and we welcome contact from companies interested in licensing any of our technologies.

Click here to see our current portfolio of licensing opportunities.

Consulting

Staff from the ICR are available for external consultancy work enabling us to share our knowledge with industry, government and the public sector. We work closely with clients in business and industry to meet their needs and the Enterprise Unit can assist you in finding suitable expertise.

Clinical trials contracts

ICR staff participate in numerous clinical trials projects to study investigational new drugs or treatment regimens. These studies are often funded by pharmaceutical companies or other external partners. The Enterprise Unit is responsible for reviewing and negotiating clinical trials contracts on behalf of the ICR and our clinical partner The Royal Marsden NHS Foundation Trust.

Spinouts

The Enterprise Unit also forms its own companies, known as spinout companies as a means of commercialising ICR research leading to the formation of sustainable businesses which contribute to the economic activity of the UK.

 
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.